Marine Drugs (Aug 2018)

A Novel Peptide, Nicotinyl–Isoleucine–Valine–Histidine (NA–IVH), Promotes Antioxidant Gene Expression and Wound Healing in HaCaT Cells

  • Dong Hwee Son,
  • Dong Joo Yang,
  • Ji Su Sun,
  • Seul Ki Kim,
  • Namju Kang,
  • Jung Yun Kang,
  • Yun-Hee Choi,
  • Jeong Hun Lee,
  • Sang Hyun Moh,
  • Dong Min Shin,
  • Ki Woo Kim

DOI
https://doi.org/10.3390/md16080262
Journal volume & issue
Vol. 16, no. 8
p. 262

Abstract

Read online

Nicotinamide (NA), a water-soluble vitamin B3, has been shown to exert cellular-protective effects against reactive oxygen species (ROS). In order to improve the cellular-protective effects of NA, we synthesized a novel compound, nicotinyl–isoleucine–valine–histidine (NA–IVH), by combining NA with jellyfish peptides’ IVH. In the present study, we examined the cellular-protective effects of the novel synthetic nicotinyl-peptide, NA–IVH. We found that NA–IVH enhances the radical scavenging activity with a robust increase of the nuclear factor (erythroid-derived 2)-like factor (Nrf2) expression in human HaCaT keratinocytes. In addition, NA–IVH protected the cells from hydrogen peroxide (H2O2)-induced cell death. Interestingly, NA–IVH exhibited an improved wound-healing effect in a high glucose condition, possibly through the regulation of reactive oxygen species (ROS). Collectively, our results imply that a novel nicotinyl-peptide, NA–IVH, has a wound-healing effect in a hyperglycemic condition, possibly by modulating excessive ROS.

Keywords